Related Experiment Video

Updated: Oct 3, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Estimating duration of HIV infection with CD4 cell count and HIV-1 RNA at presentation

E Girardi, C Arici, M Ferrara

    AIDS (London, England)
    |October 31, 2001
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
    13:58

    Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

    Published on: September 26, 2011

    Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
    11:14

    Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture

    Published on: October 12, 2018

    Related Experiment Videos

    Last Updated: Oct 3, 2026

    Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
    07:10

    Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

    Published on: January 7, 2019

    Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
    13:58

    Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

    Published on: September 26, 2011

    Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
    11:14

    Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture

    Published on: October 12, 2018

    Related Concept Videos

    Retrovirus Life Cycles01:10

    Retrovirus Life Cycles

    Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...

    Articles linked to this work by shared authors, journal, and citation graph.

    Long-term trajectories of hepatic and metabolic biomarkers after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral therapy-experienced people with HIV with and without hepatic coinfection: Data from the ICONA cohort.

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2025

    Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians' and nurses' points of view.

    The Journal of antimicrobial chemotherapy·2024

    Clinical characteristics of women with HIV in the RESPOND cohort: A descriptive analysis and comparison to men.

    HIV medicine·2024

    Investigating coping and stigma in people living with HIV through narrative medicine in the Italian multicentre non-interventional study DIAMANTE.

    Scientific reports·2023

    Self-induced nail disorders (SINDs): What do we know so far?

    Annales de dermatologie et de venereologie·2023

    Diagnosis and Management of Intravenous Drug Users' Chronic Wounds: A Case Series Collection of a Single Center.

    The international journal of lower extremity wounds·2022

    HIV-associated pulmonary arterial hypertension: improving survival despite persistent treatment gaps - a systematic review and meta-analysis.

    AIDS (London, England)·2026

    Real-life durability and virological outcomes of doravirine in people with multidrug-resistant HIV.

    AIDS (London, England)·2026

    Retention in care: is it still a clinically useful indicator for monitoring long-term engagement in HIV care in the treat-all era?

    AIDS (London, England)·2026

    Cancer incidence and risk factors among people with HIV in REPRIEVE.

    AIDS (London, England)·2026

    Effects of semaglutide on subclinical cardiovascular health in people with HIV.

    AIDS (London, England)·2026

    Antiretroviral therapy regimens initiated during pregnancy and risks of adverse perinatal outcomes.

    AIDS (London, England)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us